|
Apr 28
|
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
|
|
Apr 27
|
IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
|
|
Apr 25
|
Strength Seen in IDEAYA Biosciences, Inc. (IDYA): Can Its 35.7% Jump Turn into More Strength?
|
|
Apr 25
|
IDEAYA Announces Pricing of Public Offering
|
|
Apr 24
|
IDEAYA Announces Proposed Public Offering of Common Stock
|
|
Apr 24
|
IDEAYA Biosciences Touts Encouraging Data From Combo Therapy For Rare Eye Cancer Impacting Around 14,000 In US and Europe
|